BNTX BioNTech SE American Depositary Share Loading...

From GILD earnings calls
Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
All directions✓
▲ Long✓
▼ Short✓
⛔ Avoid✓
✂ Close✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
21:30
Feb 10 ◎
Daniel O'Day CEO, Gilead Sciences, Inc. GILD Q4 FY25 call
Gilead's oncology pipeline competes with BioNTech's in breast cancer and solid tumors.
BNTX
LOW

About BNTX Analyst Coverage

Buzzberg tracks BNTX (BioNTech SE American Depositary Share) across 1 sources. 0 bullish vs 0 bearish calls from 1 analysts. Sentiment: evenly split. 1 total trade idea tracked. Latest voices: Daniel O'Day.